In this study, we present the clinical, laboratory, and genetic characteristics of patients diagnosed with SRD5A2-associated 46,XY disorders of sex development (DSD), along with the decisions made by the Multidisciplinary Gender Assessment Committee (GAC). Here, SRD5A2 is linked to disorder of sexual differentiation.